Company · CIK 1817241

# Artiva Biotherapeutics, Inc.

| CIK | [1817241](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001817241) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ARTV (Nasdaq) |
| First annual or quarterly report | 2024-08-29 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298088 | Shelf Effective | 2026-08-06 | 2026-08-14 | 2 |
| 333-289325 | Shelf Effective | 2025-08-06 | 2026-05-08 | 3 |
| 333-280568 | IPO Final prospectus | 2024-06-28 | 2024-07-22 | 4 |
| 333-255135 | First-time registration Withdrawn | 2021-04-08 | 2022-11-01 | 6 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1817241/999999999526002667/9999999995-26-002667-index.htm) Declared effective | 333-298088 | 9999999995-26-002667 |
| 2026-08-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1817241/000119312526338453/0001193125-26-338453-index.htm) Shelf registered | 333-298088 | 0001193125-26-338453 |
| 2026-05-08 | [424B5](https://www.sec.gov/Archives/edgar/data/1817241/000119312526214706/0001193125-26-214706-index.htm) Shelf takedown | 333-289325 | 0001193125-26-214706 |
| 2025-08-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1817241/999999999525002641/9999999995-25-002641-index.htm) Declared effective | 333-289325 | 9999999995-25-002641 |
| 2025-08-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1817241/000119312525174570/0001193125-25-174570-index.htm) Shelf registered | 333-289325 | 0001193125-25-174570 |
| 2024-07-22 | [424B4](https://www.sec.gov/Archives/edgar/data/1817241/000119312524181773/0001193125-24-181773-index.htm) Final prospectus | 333-280568 | 0001193125-24-181773 |
| 2024-07-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1817241/999999999524002197/9999999995-24-002197-index.htm) Declared effective | 333-280568 | 9999999995-24-002197 |
| 2024-07-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1817241/000119312524178806/0001193125-24-178806-index.htm) Amendment | 333-280568 | 0001193125-24-178806 |
| 2024-06-28 | [S-1](https://www.sec.gov/Archives/edgar/data/1817241/000119312524172230/0001193125-24-172230-index.htm) Registration filed | 333-280568 | 0001193125-24-172230 |
| 2024-05-03 | [DRS](https://www.sec.gov/Archives/edgar/data/1817241/000095012324003803/0000950123-24-003803-index.htm) Draft made public | 377-07214 | 0000950123-24-003803 |
| 2022-11-01 | [RW](https://www.sec.gov/Archives/edgar/data/1817241/000119312522275086/0001193125-22-275086-index.htm) Withdrawn | 333-255135 | 0001193125-22-275086 |
| 2022-06-06 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1817241/000119312522168492/0001193125-22-168492-index.htm) Amendment | 333-255135 | 0001193125-22-168492 |
| 2022-03-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1817241/000119312522068001/0001193125-22-068001-index.htm) Amendment | 333-255135 | 0001193125-22-068001 |
| 2022-01-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1817241/000119312522014926/0001193125-22-014926-index.htm) Amendment | 333-255135 | 0001193125-22-014926 |
| 2021-12-16 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1817241/000119312521358277/0001193125-21-358277-index.htm) Amendment | 333-255135 | 0001193125-21-358277 |
| 2021-04-08 | [S-1](https://www.sec.gov/Archives/edgar/data/1817241/000119312521110347/0001193125-21-110347-index.htm) Registration filed | 333-255135 | 0001193125-21-110347 |
| 2021-03-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1817241/000095012321003225/0000950123-21-003225-index.htm) Draft made public | 377-04338 | 0000950123-21-003225 |

[All filings of this company](https://equitycapital.markets/filings?cik=1817241) · [CSV](https://equitycapital.markets/filings.csv?cik=1817241)

---
Source page: https://equitycapital.markets/company/1817241 · Data: U.S. SEC EDGAR · CC BY 4.0